1. Home
  2. EOLS vs MVIS Comparison

EOLS vs MVIS Comparison

Compare EOLS & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • MVIS
  • Stock Information
  • Founded
  • EOLS 2012
  • MVIS 1993
  • Country
  • EOLS United States
  • MVIS United States
  • Employees
  • EOLS N/A
  • MVIS N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • MVIS Industrial Machinery/Components
  • Sector
  • EOLS Health Care
  • MVIS Technology
  • Exchange
  • EOLS Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • EOLS 406.9M
  • MVIS 403.3M
  • IPO Year
  • EOLS 2018
  • MVIS 1996
  • Fundamental
  • Price
  • EOLS $6.50
  • MVIS $1.42
  • Analyst Decision
  • EOLS Strong Buy
  • MVIS Strong Buy
  • Analyst Count
  • EOLS 4
  • MVIS 3
  • Target Price
  • EOLS $21.25
  • MVIS $2.50
  • AVG Volume (30 Days)
  • EOLS 1.0M
  • MVIS 5.6M
  • Earning Date
  • EOLS 11-05-2025
  • MVIS 11-06-2025
  • Dividend Yield
  • EOLS N/A
  • MVIS N/A
  • EPS Growth
  • EOLS N/A
  • MVIS N/A
  • EPS
  • EOLS N/A
  • MVIS N/A
  • Revenue
  • EOLS $277,941,000.00
  • MVIS $2,584,000.00
  • Revenue This Year
  • EOLS $13.68
  • MVIS N/A
  • Revenue Next Year
  • EOLS $27.96
  • MVIS $857.46
  • P/E Ratio
  • EOLS N/A
  • MVIS N/A
  • Revenue Growth
  • EOLS 17.15
  • MVIS N/A
  • 52 Week Low
  • EOLS $5.71
  • MVIS $0.80
  • 52 Week High
  • EOLS $17.82
  • MVIS $1.95
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 44.82
  • MVIS 70.73
  • Support Level
  • EOLS $6.08
  • MVIS $1.23
  • Resistance Level
  • EOLS $6.36
  • MVIS $1.31
  • Average True Range (ATR)
  • EOLS 0.22
  • MVIS 0.08
  • MACD
  • EOLS 0.04
  • MVIS 0.01
  • Stochastic Oscillator
  • EOLS 71.96
  • MVIS 83.33

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: